Ingredion Completes Reorganization, Reports First Quarter Earnings Under New Segments and Raises Guidance
GlobeNewswire
· First quarter 2024 reported and adjusted EPS^* were $3.23 and $2.08, an increase of 13% and decrease of 26%,..
· First quarter 2024 reported and adjusted EPS^* were $3.23 and $2.08, an increase of 13% and decrease of 26%,..
The Pakistan Stock Exchange maintained its bullish momentum during the week ended on April 26, 2024. Despite some profit-takings,..
· SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic..